Skip to content

US · ONMD · MEDICAL - HEALTHCARE INFORMATION SERVICES

OneMedNet Corporation (ONMD) intrinsic value and stock valuation

$4.70as of 2026-11-21 · Mkt cap 35.57M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

OneMedNet Corporation DCF and intrinsic value

InvestorsCraft values ONMD with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from ONMD’s statements →

OneMedNet Corporation Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Eden Prairie, MN 55344 onemednet.com

How the business is doing

Fiscal 2020–2025, USD

Revenue
$1.36M+10.6% 5y CAGRd
20202025
Net income
-$-2.8M
20202025
Free cash flow
-$-7.52M
20202025
Total equity
-$-2.96M
20202025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2020–2025, USD
20252024202320222021
Revenue$1.36M$640K$1.02M$1.15M$1.09M
Operating income-$-9.67M-$-9.61M-$-6.85M-$-7.71M-$-2.71M
Net income-$-2.8M-$-10.13M-$-33.78M-$-30.45M-$-2.94M
EPSd-$-62.85K-$-360.75K-$-4.77M-$-2.51M-$-196.52K
Operating cash flow-$-7.5M-$-6.98M-$-4.79M-$-4.7M-$-1.84M
Capital expenditure-$-10K-$-50K-$-40K-$-60K-$-30K
Free cash flow-$-7.52M-$-7.03M-$-4.83M-$-4.76M-$-1.87M
Total assets$2.15M$3.73M$460K$1.29M$880K
Total debt$570K$8.76M$5.1M$26.2M$4.9M
Net debt-$-10K$8.59M$5.05M$26M$4.2M
Total equity-$-2.96M-$-15.95M-$-12.86M-$-26.36M-$-5.7M
Cash and short-term investments$1.09M$3.02M$50K$270K$700K
Income statement
20252024202320222021
Revenue$1.36M$640K$1.02M$1.15M$1.09M
Cost of revenue$1.86M$920K$1.15M$1.51M$1.21M
Gross profit-$-500K-$-280K-$-130K-$-360K-$-110K
Research and development expenses$1.51M$1.47M$2.06M$1.59M$640K
Selling, general and administrative expenses$7.65M$7.86M$4.66M$13.8M$1.8M
Other expenses$0.00$0.00$0.00-$-8.07M$150K
Operating expenses$9.16M$9.32M$6.72M$7.36M$2.6M
Cost and expenses$11M$10.3M$7.87M$8.87M$3.8M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$70K$150K$10K$400K$200K
Depreciation and amortization$70K$60K$30K$30K$10K
Ebitda-$-2.67M-$-9.92M-$-33.72M-$-30.41M-$-2.73M
Operating income-$-9.67M-$-9.61M-$-6.85M-$-7.71M-$-2.71M
Total other income/expenses, net$6.87M-$-520K-$-26.91M-$-22.72M-$-230K
Income before tax-$-2.8M-$-10.13M-$-33.76M-$-30.43M-$-2.94M
Income tax expense$0.00$0.00$20K$20K$0.00
Net income-$-2.8M-$-10.13M-$-33.78M-$-30.45M-$-2.94M
Weighted average shares outstanding$44.6M$28.1M$7.08M$12.1M$15M
Weighted average diluted shares outstanding$44.6M$28.1M$7.08M$12.1M$15M
Balance sheet
20252024202320222021
Cash and short-term investments$1.09M$3.02M$50K$270K$700K
Net receivables$490K$210K$150K$20K$90K
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$2.1M$3.62M$360K$390K$830K
Property, plant and equipment, net$60K$110K$100K$80K$50K
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$60K$110K$100K$900K$50K
Total assets$2.15M$3.73M$460K$1.29M$880K
Accounts payable$0.00$6.37M$4.18M$1.18M$0.00
Short-term debt$350K$8.76M$4.64M$24.7M$3.35M
Deferred revenue$390K$560K$250K$180K$640K
Total current liabilities$4.83M$19.2M$12.8M$26.1M$4.75M
Long-term debt$220K$0.00$470K$1.5M$1.55M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$290K$450K$490K$1.54M$1.83M
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$5.12M$19.7M$13.3M$27.7M$6.59M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-104.37M-$-101.57M-$-55.08M-$-57.66M-$-25.31M
Accumulated other comprehensive income (loss)$0.00$0.00-$0.00$0.00$0.00
Total equity-$-2.96M-$-15.95M-$-12.86M-$-26.36M-$-5.7M
Total investments$510K$2.85M$0.00$0.00$0.00
Total debt$570K$8.76M$5.1M$26.2M$4.9M
Net debt-$-10K$8.59M$5.05M$26M$4.2M
Cash flow statement
20252024202320222021
Net income-$-2.8M-$-10.13M-$-33.78M-$-30.45M-$-2.94M
Depreciation and amortization$70K$60K$30K$30K$10K
Stock-based compensation$2.03M$630K$1.48M$1.86M$100K
Change in working capital$110K$1.5M$610K-$-30K$980K
Accounts receivable-$-280K-$-60K-$-130K$70K$80K
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$0.00$1.49M$720K$1.93M$0.00
Net cash provided by operating activities-$-7.5M-$-6.98M-$-4.79M-$-4.7M-$-1.84M
Investments in property, plant and equipment-$-10K-$-50K-$-40K-$-60K-$-30K
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$2.31M-$-1.98M-$-40K-$-60K-$-30K
Common stock issued$2.56M$6.27M$0.00$2.83M$0.00
Common stock repurchased$0.00-$-200K$0.00-$-88.55M$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$5.61M$9.09M$4.61M$4.33M$2.49M
Net change in cash$410K$120K-$-220K-$-430K$620K
Cash at end of period$580K$170K$50K$270K$700K
Operating cash flow-$-7.5M-$-6.98M-$-4.79M-$-4.7M-$-1.84M
Capital expenditure-$-10K-$-50K-$-40K-$-60K-$-30K
Free cash flow-$-7.52M-$-7.03M-$-4.83M-$-4.76M-$-1.87M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About OneMedNet Corporation

        OneMedNet Corporation offers advanced solutions for clinical imaging. Their core product, iRWD, is an artificial intelligence-driven platform that securely anonymizes, searches for, and organizes imaging data. This system is utilized by their extensive network of medical and academic research institutions, with the goal of fostering significant progress in medical research, new discoveries, and diagnostic techniques across the broader field of life sciences. The company's operations are based out of Eden Prairie, Minnesota.

        CEO
        Aaron Green
        Employees
        23
        Beta
        1.14

        Explore

        Frequently asked questions

        What is the intrinsic value of OneMedNet Corporation (ONMD)?

        OneMedNet Corporation (ONMD) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is ONMD undervalued?

        ONMD trades at a price of $4.70 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.